Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

Participants on weekly injections of 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks, and 45.3% of participants achieved ≥ 30% weight loss.

A new study finds that prior authorization requirements vary widely across major insurers and suggests large language models ...

Pediatric hypertension is a significant concern because it can persist into adulthood and contribute to cardiovascular ...

Analysis of data from the PUSH randomized trial affirmed that more fluid increase is better, but some still helps.

Biopsy and next-generation sequencing identified an HSV 1 variant causing ulcerative esophagitis and ileitis in a healthy 26 ...

An analysis conducted in an integrated healthcare system provided insights into the long-term healthcare burden of cCMV ...

Creatinine muscle index can serve as a blood biomarker to estimate low muscle mass and identify individuals at an increased ...

Nutrition science is closing in on truly personalized dietary advice. The bigger challenge? Making sure it does not only land ...

Rapid microbiological point-of-care testing for respiratory tract infections does not reduce overall same-day antibiotic prescribing in primary care, a recent study shows.

The FDA’s recent approval of baxdrostat may usher in new possibilities for treatment for uncontrolled hypertension.

Despite rising cases in recent years, lentigo maligna shows minimal progression to melanoma, and patients with this condition ...